Clinical Trial Update: Impacts of Aldosterone Blockade on Myocardial Remodeling in Hypertensive Patients With Diastolic Failing Heart [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating aldosterone blockade to assess effects on myocardial remodeling in hypertensive patients with diastolic heart failure has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Diastolic Heart Failure | Phase 4 | Status: COMPLETED